Search results
Results from the WOW.Com Content Network
[9] He was also elected as the Cancer Immunology Working Group (CIMM) Chairperson-Elect for 2020–2021. [10] During the COVID-19 pandemic, Odunsi was named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors which began in January 2021. [11]
Fathman has chaired a variety of national and international professional meetings, served on NIH study sections and numerous blue ribbon panels and has written more than 300 articles on his research in molecular and cellular immunology. [4] Council of ASCI; President of the Clinical Immunology Society;
In 1989, Lenardo established an independent research section in the Laboratory of Immunology at NIAID, later becoming a senior investigator and section chief. [4] He was named a NIH Distinguished Investigator in 2019, a title reserved only for the top 2-3% of investigators across all 27 institutes and centers at NIH. [1] [14]
Molecular Immunology and Inflammation Branch (MIIB) The MIIB conducts basic and clinical investigations on the molecular mechanisms underlying immune and inflammatory responses in rheumatic and autoimmune diseases. A major focus of the Branch is the study of receptor-mediated signal transduction and how these events link to the regulation of ...
John R. Mascola, Director of the Vaccine Research Center Bill Gates, Francis Collins, Anthony Fauci, John R. Mascola, and NIH Vaccine Research Center scientists. The origins of the Vaccine Research Center date back to 1996 following discussions between President Bill Clinton and NIAID Director Dr. Anthony Fauci regarding research addressing HIV/AIDS.
Nabel completed his undergraduate, M.D., and Ph.D. studies at Harvard University (1975, 1980, and 1982, respectively). He completed his dissertation research in the laboratory of immunologist Harvey Cantor and then worked as a postdoctoral fellow in the laboratory of David Baltimore at the Whitehead Institute, studying regulation of HIV gene expression by the recently discovered NF-κB, a host ...
In 2013, while reorganizing the Laboratory of Cellular and Molecular Immunology, NIAID transferred Matzinger's section to the Laboratory of Immunogenetics. [6] In 2015, Matzinger recorded an eight-part series on the danger model of the immune system, covering transplant rejection, tumors, autoimmunity, T cells, parasites, and alarmins. [7]
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) [2] is a Japanese physician-scientist and immunologist.He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). [3]